November 2020 - Page 13 of 27

TuesdayNov 17, 2020 11:20 am

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Announces Financial Numbers, Key Milestones for Third Quarter

Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary technology platform for creators of all types, reported its financial numbers and outlined several business milestones achieved during its three-month and nine-month periods ending Sept. 30, 2020. Highlights of the report include Q3 revenues of $425,000, an increase of more than 32% compared to Q2 revenues of $323,000 and a fourfold increase over revenues of $91,000 for the same period last year. The company attributed the growth in revenues primarily to the increase of Vocal+ paid subscribers and the rising price points for Vocal for Brands' campaigns. Other highlights include the appointment of…

TuesdayNov 17, 2020 11:01 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces Fiscal Q2 Results

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, on Monday announced revenue of $10.8 million for the fiscal second quarter ended September 30, 2020. “During the fiscal second quarter, we made good progress toward our strategic goals, gained market share, launched innovating new products, added leading partners, and expanded into new growth markets, all while navigating through a challenging COVID environment. Our quarterly growth was impacted as various distributors reduced deliveries and cleared excess inventory built in the prior quarter. Delivery and inventory trends continued to improve…

TuesdayNov 17, 2020 10:24 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Conference Call to Discuss Q3 Finances, Business Update

Pressure BioSciences (OTCQB: PBIO) has scheduled a teleconference for today to release its third-quarter 2020 financial results and announce key business updates. PBIO is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries. The call, scheduled for today, Nov. 17, at 4:30 p.m. ET., will include a presentation followed by a Q&A session. Anyone in North America who is interested may attend the teleconference live by calling 877-407-8033 and using the verbal passcode PBI Third Quarter 2020 Financial Call and Business Update. Those living…

TuesdayNov 17, 2020 10:17 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Files IND Application for Berubicin in Treatment of GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has submitted an Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”) for Berubicin in the treatment of Glioblastoma Multiforme (“GBM”). Pending the FDA's acceptance of the company's filing, CNS Pharmaceuticals plans to evaluate the efficacy of Berubicin in a Phase 2 Trial for adults with GBM who have failed first-line therapy and commence the trial within the first quarter of 2021. “Our laser focus from…

TuesdayNov 17, 2020 10:12 am

Pressure BioSciences’ (PBIO) First Issued U.S. Patent for Its Novel UST Platform Advances the Company Toward 2021 Product Delivery, Significant Acceleration of Revenue, and Profitability

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) has increased its IP stable to 26 patents worldwide with the announcement of its first U.S. patent for its revolutionary Ultra Shear Technology(TM) (“UST”) Platform The patent (US 10,823,159) - entitled “System for High Pressure, High Shear Processing of Fluids” - will be the framework of the company’s new instrument line (the BaroShear K45 Nanoemulsification System) to be commercially released in mid-2021 UST is expected to revolutionize the processing of immiscible liquids into high quality, highly profitable nanoemulsions Nanoemulsions are highly sought after in a variety of industries because of their ability…

MondayNov 16, 2020 3:20 pm

HempFusion Wellness Builds Reputation for Safety in the Global CBD Market, Aims to IPO on TSX Exchange

HempFusion Wellness, Inc. is a health and wellness company developing the power of whole-food hemp nutrition through more than 40 products currently on store shelves The company is focused on industry safety and quality standards through regulatory compliance, and is currently participating in a real world consumer study to establish the safety of daily cannabidiol (“CBD”) use in regard to liver function HempFusion has filed a preliminary prospectus for a planned initial public offering of its stock in Canada and a listing on the Toronto Stock Exchange Despite a reduction in hemp farm acreage this year following last year’s glut,…

MondayNov 16, 2020 2:57 pm

Knightscope, Inc.’s AI-equipped Security Robots Building Confidence in Law Enforcement Sector

Knightscope is building a clientele for its robotic security force models, including about dozens of clients from Fortune 1000 companies, to law enforcement agencies, hospitals, casinos, water utilities, malls and manufacturing plants The company’s robots use artificial intelligence to navigate indoor and outdoor areas that are Americans with Disabilities Act compliant, and can be monitored with a simple browser and Internet connection The robots record data and use recognition features to assess potentially significant elements such as human activities, thermal changes and license plate information The privately held company is backed by more than 16,000 investors and four major corporations,…

MondayNov 16, 2020 2:19 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation Schedule for Upcoming Investor Conferences

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will participate in two upcoming investor conferences. According to the update, Processa will participate in one-on-one meetings at the Craig-Hallum Alpha Select Virtual Conference on Tuesday, Nov. 17, 2020, and the Benchmark Annual Discovery 1x1 Investor Virtual Conference on Wednesday, Nov. 18, 2020. Interested parties should contact their conference representative or James@HaydenIR.com to schedule a one-on-one meeting with management. To view the full press release, visit https://ibn.fm/bQAkg About Processa Pharmaceuticals Inc.…

MondayNov 16, 2020 12:26 pm

Predictive Oncology (NASDAQ: POAI) CEO Discusses Subsidiaries’ Proprietary Tech, Innovative Media

CEO expects results that will “build the stock and raise the stock price” POAI focused on positioning TumorGenesis kits to manufacturers Helomics has largest database of its kind in the world, brings cutting-edge technology to cancer research During a recent NetworkNewsWire exclusive audio interview, Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz noted recent company milestones and outlined strategic goals. In addition, Schwartz provided key updates on the company’s four impressive subsidiaries: Skyline Medical, TumorGenesis, Soluble Biotech and Helomics. “I’m very encouraged. I think we’re moving right along. Things never go as fast as we would like them, and it can be…

MondayNov 16, 2020 12:22 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces 161% YoY, 124% QoQ Revenue Growth

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, announced results for the three months ended September 30, 2020. Among the highlights, the company reported $2.6 million in total revenue for Q3, which represents 161% year-over-year (“YoY”) and 124% sequentially quarter-over-quarter (“QoQ”) growth. “As the Sequire platform continues to grow and adapt to customer needs, we are seeing a tremendous increase in our recurring revenue stream,” said Chris Miglino, founder and CEO of SRAX. “Sequire is changing the way public issuers interact with and engage their investors, and it shows. We…

Site Search

Company Search

Month: November 2020